RT1 | 200 ml – Whipped Research Tallow with GHK-Cu

For research use only — not for human or veterinary use.

Analytical Verification (Formulation Standard)

RT1 is produced using controlled formulation protocols combining a whipped lipid base with analytically verified GHK-Cu peptide. Each batch is prepared under laboratory conditions to ensure consistent peptide integration and structural stability.

Batch: RT1-GF-GHK-200

Formulation characteristics include:

• Base Matrix: grass-fed whipped tallow
• Peptide Component: GHK-Cu (Copper Tripeptide-1)
• Lipid Components: jojoba oil and squalane
• Botanical Components: rose oil and lavender
• Stabilization: vitamin E
• Structure: uniform whipped lipid matrix with peptide integration
• Packaging: violet glass jar for light protection and formulation stability

The peptide component is incorporated using controlled mixing procedures to support uniform distribution and reproducible research performance.

Product Overview

RT1 200 ml Whipped Research Tallow with GHK-Cu is a peptide-infused lipid formulation developed for controlled experimental environments involving peptide–matrix interaction and formulation behaviour.

This formulation builds upon the RT0 base system and introduces GHK-Cu as an active research component, allowing comparative analysis between non-active and peptide-infused matrices.

The whipped structure provides a stable and reproducible environment for evaluating distribution, interaction behaviour and structural influence of peptides within lipid-based systems.

RT1 is designed for in vitro research involving peptide carrier systems and formulation analysis.

Peptide Overview

GHK-Cu (Copper Tripeptide-1) is a well-characterized peptide studied in biochemical research for its role in cellular signalling and peptide-mediated pathways.

Within laboratory environments, GHK-Cu is frequently investigated in experimental models examining peptide interaction, signalling mechanisms and biochemical pathway modulation.

RT1 is formulated as a peptide-infused system with a high relative peptide content within the lipid matrix, enabling detailed analysis of peptide behaviour in a structured carrier environment.

Compound Overview

The formulation combines natural lipid components with a peptide element to create a stable research matrix.

The composition includes:

• Grass-fed tallow as structural base
• Jojoba oil for wax ester stability
• Squalane for lipid uniformity
• Rose oil and lavender for formulation consistency
• Vitamin E as antioxidant stabilizer
• GHK-Cu peptide integrated within the matrix

This combination supports controlled experimental evaluation of peptide–matrix interaction and formulation behaviour.

Historical Background and Scientific Context

GHK-Cu was first identified in the 1970s and has since been studied extensively in laboratory environments exploring peptide signalling and molecular interaction pathways.

As peptide research expanded, attention shifted toward understanding how peptides behave within carrier systems and structured formulations.

Lipid-based matrices such as whipped tallow formulations provide a controlled environment for studying peptide distribution, interaction and stability.

RT1 is developed within this context as a peptide-infused formulation enabling comparative and mechanistic research.

Mechanistic Focus in Research

RT1 enables investigation of both lipid matrix behaviour and peptide interaction within a combined system.

Research investigations commonly focus on:

• Peptide–matrix interaction analysis
• Cellular signalling research models
• Lipid carrier system behaviour
• Structural and rheological formulation analysis
• Comparative RT0 vs RT1 studies

Research Applications

RT1 is used in controlled experimental setups where peptide-infused formulations are evaluated.

Examples of research applications include:

• Peptide carrier system research
• Comparative formulation studies
• Biochemical signalling analysis
• Surface distribution research
• Controlled in vitro experiments

Packaging and Material Integrity

RT1 is supplied in a violet glass container designed to protect the formulation from light exposure and environmental factors.

This packaging supports stability of both the lipid matrix and peptide component while avoiding interaction with synthetic materials.

Grail Formula Quality

Each Grail Formula peptide formulation is produced using controlled laboratory processes to ensure consistency, peptide integrity and reproducible research performance.

All peptide materials are verified prior to formulation and integrated using standardized procedures.

• Peptide identity verification
• Controlled formulation process
• Consistent peptide distribution
• Batch traceability
• Laboratory-grade production standards

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

Peptide-infused whipped tallow research formulation
Contains GHK-Cu peptide
High peptide content within lipid matrix
Grass-fed tallow base formulation
Supplied in violet glass for light protection
Supports peptide–matrix interaction research
Stable lipid-based carrier system
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.